Latest / Spill The Tea With D&E

GLP-1 Use Among New Mothers Has Jumped
A new JAMA study found that the number of commercially insured U.S. mothers starting GLP-1 medications within six months after giving birth increased nearly 24-fold from 2018 to early 2025.
But this isn’t simply a “baby weight” story.
What about breastfeeding? Gestational diabetes? Nutrition? Future pregnancies? And are we helping women address genuine metabolic disease, or creating another impossible expectation for the postpartum body?
Dominique & Erica spill the tea on what we know, what we’re still learning and why postpartum health deserves far more nuance than a before-and-after photo…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.